Daily Archives: 17, February 2021

Digi Communications NV announces Investors Call for the 2020 Preliminary Financial Results

(PRESS RELEASE) BUCHAREST, Romania, 17-Feb-2021 — /EuropaWire/ — Digi Communications N.V. (“Digi” or the “Company”) announces that on 24 February 2021 at 14:00 UK time/ 16:00 EEST (Romania local time) it will host a conference call to discuss the 2020 … Read the full press release

Scania 540 S tractor awarded the highest overall scoring in 1000 Point and European Truck Challenge comparison tests

(PRESS RELEASE) SÖDERTÄLJE, Sweden, 17-Feb-2021 — /EuropaWire/ — Scania announces that its 540 S tractor has won two comparison tests organised in Germany by European trade magazines. The 1000 Punkte Test (1000 Point Test) and European Truck Challenge (ETC) results … Read the full press release

ANIL UZUN Will Launch Bass Guitar Lessons Series on Youtube

ANIL UZUN is going to launch a Youtube series to teach bass guitar. The lessons will start airing on Youtube on Monday, March 1, at 5pm. The lessons will be released weekly on every Monday in March and April. There … Read the full press release

SEB and Wärtsilä successfully trial ground-breaking secure data sharing in Trade Finance

(PRESS RELEASE) STOCKHOLM, 17-Feb-2021 — /EuropaWire/ — SEB announces a breakthrough achievement in secure data sharing. Together with technology group Wärtsilä, parties participated in a ground-breaking test of secure data sharing between companies in Trade Finance. The results demonstrates that … Read the full press release

A URSAPHARM Arzneimittel e a CEBINA anunciam uma parceria com vista a reaproveitar o anti-histamínico azelastina para combater a COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — Na luta contra o vírus SARS-CoV-2, um grande número de empresas farmacêuticas está em busca de novas abordagens para combater a pandemia. Além das vacinas, estão a ser feitos esforços intensivos … Read the full press release

URSAPHARM Arzneimittel et CEBINA annoncent un partenariat pour reconvertir l’antihistaminique azélastine afin de lutter contre la COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SARREBRUCK / VIENNE, 17-Feb-2021 — /EuropaWire/ — Dans la lutte contre le virus SRAS-CoV-2, un grand nombre d’entreprises pharmaceutiques recherchent de nouvelles approches pour combattre la pandémie. Outre les vaccins, des efforts intensifs de recherche et développement à … Read the full press release

URSAPHARM Arzneimittel y CEBINA anuncian una colaboración para readaptar el antihistamínico azelastine para combatir la COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — En la lucha contra el virus SARS-CoV-2, una gran cantidad de empresas farmacéuticas están buscando nuevos enfoques para combatir la pandemia. Además de las vacunas, las iniciativas exhaustivas de investigación y … Read the full press release

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts … Read the full press release